{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:57:04Z","timestamp":1761865024318,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.joim.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T21:23:22Z","timestamp":1655155402000},"page":"476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 and angiotensin-converting enzyme inhibitors from plant origin"],"prefix":"10.1016","volume":"20","author":[{"given":"Reza","family":"Gharebaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Heidary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.joim.2022.06.005_b0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.joim.2021.09.006","article-title":"Angiotensin-converting enzyme inhibitors from plants: a review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications","volume":"19","author":"Chakraborty","year":"2021","journal-title":"J Integr Med"},{"issue":"COVID-19","key":"10.1016\/j.joim.2022.06.005_b0010","first-page":"e102838","article-title":"The potential use of Persian herbal medicines against COVID-19 through angiotensin-converting enzyme 2. Arch","volume":"15","author":"Heidary","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.joim.2022.06.005_b0015","doi-asserted-by":"crossref","first-page":"629935","DOI":"10.3389\/fphar.2021.629935","article-title":"Natural products modulating angiotensin converting enzyme 2 (ACE2) as potential COVID-19 therapies","volume":"12","author":"Abubakar","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.joim.2022.06.005_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13020-021-00427-0","article-title":"The important herbal pair for the treatment of COVID-19 and its possible mechanisms","volume":"16","author":"Xia","year":"2021","journal-title":"Chin Med"},{"issue":"10","key":"10.1016\/j.joim.2022.06.005_b0025","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1386207323666201110152615","article-title":"Tinocordiside from Tinospora cordifolia (Giloy) may curb SARS-CoV-2 contagion by disrupting the electrostatic interactions between host ACE2 and viral S-protein receptor binding domain","volume":"24","author":"Balkrishna","year":"2021","journal-title":"Comb Chem High Throughput Screen"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496422000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496422000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:10Z","timestamp":1761864730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496422000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2095496422000711"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2022.06.005","relation":{},"ISSN":["2095-4964"],"issn-type":[{"type":"print","value":"2095-4964"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and angiotensin-converting enzyme inhibitors from plant origin","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}